Skip to main content

SVB Financial Group

SEC CIK
0000719739
Latest filing
Nov 10, 2025

Holdings in Q4 2023

Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only; changes compare share counts with Q3 2023.

Institution overview
Positions
13
−8 vs. Q3 2023
Portfolio value
$112.8M
+$59.7M (+112.2%) vs. Q3 2023
Filed
Feb 14, 2024
SEC
Holdings of SVB Financial Group in Q4 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
COINCoinbase Global, Inc.COM CL A531,319$92.4M81.9%+124,346+30.6%AddedHistory
ROOTRoot, Inc.CL A NEW783,012$8.21M7.3%00.0%UnchangedHistory
OKTAOkta, Inc.CL A79,152$7.17M6.4%00.0%UnchangedHistory
AXSMAxsome Therapeutics, Inc.COM33,849$2.69M2.4%00.0%UnchangedHistory
OBIOOrchestra BioMed Holdings, Inc.COM127,068$1.16M1.0%00.0%UnchangedHistory
PLPlanet Labs PBCCOM CL A172,097$425.1K0.4%00.0%UnchangedHistory
MLMoneylion Inc.COMM STK3,729$233.7K0.2%+3,729NewHistory
GLBEGlobal-E Online Ltd.SHS5,114$202.7K0.2%00.0%UnchangedHistory
PACBPacific Biosciences of California, Inc.COM20,586$201.9K0.2%+10,337+100.9%AddedHistory
FIRYFiry Inc.COM13,950$86.8K0.1%00.0%UnchangedHistory
MVLAMovella Holdings Inc.COM55,528$33.6K<0.1%00.0%UnchangedHistory
GETRGetaround, IncCOM27,094$6.37K<0.1%+27,094NewHistory
MKULMolekule Group, Inc.COM14,165$142<0.1%−7,082−33.3%ReducedHistory

Sold out since Q3 2023 (10)

Positions held at the end of Q3 2023 that are gone from this filing.

Positions of SVB Financial Group sold out since Q3 2023
SecurityClassShares in Q3 2023Value in Q3 2023% of portfolio in Q3 2023History
GPCRStructure Therapeutics Inc.SPONSORED ADS35,353$1.78M3.4%History
MLTXMoonLake ImmunotherapeuticsCLASS A ORD16,173$921.9K1.7%History
ROVRRover Group, Inc.COMMON STOCK105,534$660.6K1.2%History
CMAXCareMax, Inc.COM CL A300,000$636.0K1.2%History
CGEMCullinan Therapeutics, Inc.COM13,516$122.3K0.2%History
CRBUCaribou Biosciences, Inc.COM20,714$99.0K0.2%History
GBIOGeneration Bio Co.COM25,034$94.9K0.2%History
KLRSKalaris Therapeutics, Inc.COM17,207$37.0K0.1%History
VEROVenus Concept Inc.COM10,667$20.9K<0.1%History
ELDNEledon Pharmaceuticals, Inc.COM13,472$18.5K<0.1%History